HIGH-DOSE AZQ IN RENAL-CANCER - A SOUTHWEST ONCOLOGY GROUP PHASE-II STUDY

被引：0
|
作者：
STEPHENS, RL
KIRBY, R
CRAWFORD, ED
BUKOWSKI, R
RIVKIN, SE
OBRYAN, RM
机构：
[1] UNIV KANSAS,MED CTR,KANSAS CITY,KS 66103
[2] UNIV MISSISSIPPI,MED CTR,JACKSON,MS 39216
[3] CLEVELAND CLIN EDUC FDN,CLEVELAND,OH 44106
[4] HENRY FORD HOSP,DETROIT,MI 48202
来源：
INVESTIGATIONAL NEW DRUGS | 1986年 / 4卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：57 / 59
页数：3
相关论文
共 50 条
  • [31] HIGH-DOSE MEGESTROL-ACETATE THERAPY OF OVARIAN-CARCINOMA - A PHASE-II STUDY BY THE NORTHERN CALIFORNIA ONCOLOGY GROUP
    SIKIC, BI
    SCUDDER, SA
    BALLON, SC
    SORIERO, OM
    CHRISTMAN, JE
    SUEY, L
    EHSAN, MN
    BRANDT, AE
    EVANS, TL
    SEMINARS IN ONCOLOGY, 1986, 13 (04) : 26 - 32
  • [32] A PHASE-II TRIAL OF DIAZIQUONE (AZQ) IN MIXED MESODERMAL SARCOMAS OF THE UTERUS - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    SLAYTON, RE
    BLESSING, JA
    CLARKEPEARSON, D
    INVESTIGATIONAL NEW DRUGS, 1991, 9 (01) : 93 - 94
  • [33] PHASE-II EVALUATION OF AMONAFIDE IN ADVANCED SARCOMA - A SOUTHWEST-ONCOLOGY-GROUP STUDY
    BUYS, SS
    METCH, B
    BALCERZAK, SP
    NEEFE, JR
    STUCKEY, WJ
    CANCER INVESTIGATION, 1994, 12 (04) : 399 - 402
  • [34] IFOSFAMIDE IN THE MANAGEMENT OF MALIGNANT-MELANOMA - A SOUTHWEST ONCOLOGY GROUP PHASE-II STUDY
    COSTANZI, JJ
    STEPHENS, R
    OBRYAN, R
    FRANKS, J
    SEMINARS IN ONCOLOGY, 1982, 9 (04) : 93 - 95
  • [35] PHASE-II TRIAL OF MITOXANTRONE IN ADVANCED SARCOMAS - A SOUTHWEST-ONCOLOGY-GROUP STUDY
    BULL, FE
    VONHOFF, DD
    BALCERZAK, SP
    STEPHENS, RL
    PANETTIERE, FJ
    CANCER TREATMENT REPORTS, 1985, 69 (02): : 231 - 233
  • [36] PHASE-II STUDY OF SULOFENUR (LY186641) IN MEASURABLE METASTATIC RENAL-CANCER
    WEINERMAN, B
    EISENHAUER, E
    STEWART, D
    MERTENS, W
    TANNOCK, I
    VENNER, P
    SPAULDING, R
    ANNALS OF ONCOLOGY, 1992, 3 (01) : 83 - 84
  • [37] High-dose melphalan with autotransplantation for refractory multiple myeloma: Results of a southwest oncology group phase II trial
    Vesole, DH
    Crowley, JJ
    Catchatourian, R
    Stiff, PJ
    Johnson, DB
    Cromer, J
    Salmon, SE
    Barlogie, B
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (07) : 2173 - 2179
  • [38] HIGH-DOSE EPIRUBICIN IN REFRACTORY OR RELAPSED NONSEMINOTAMOUS TESTICULAR CANCER - A PHASE-II STUDY
    HARSTRICK, A
    SCHMOLL, HJ
    WILKE, H
    SCHOBER, C
    STAHL, M
    WOMPNER, CK
    BOKEMEYER, C
    DOLKEN, G
    BURK, K
    POLIWODA, H
    ANNALS OF ONCOLOGY, 1990, 1 (05) : 375 - 376
  • [39] HIGH-DOSE PLATINUM CHEMOTHERAPY IN ADVANCED OVARIAN-CANCER - A PHASE-II STUDY
    BERTELSEN, K
    BASTHOLT, L
    GYNECOLOGIC ONCOLOGY, 1992, 44 (01) : 79 - 82
  • [40] PHASE-II STUDY OF HIGH-DOSE 4'-EPIDOXORUBICIN IN THE TREATMENT OF ADVANCED GASTROINTESTINAL CANCER
    VOROBIOF, DA
    FALKSON, G
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (03): : 563 - 564
12345